Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 27;2(6):100428.
doi: 10.1016/j.jacadv.2023.100428. eCollection 2023 Aug.

Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma

Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma

Leslie T Cooper Jr et al. JACC Adv. .
No abstract available

PubMed Disclaimer

References

    1. Mahmood S.S., Fradley M.G., Cohen J.V., et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71:1755–1764. - PMC - PubMed
    1. Priemer D.S., Davidson D.D., Loehrer P.J., Badve S.S. Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: a postviral autoimmune process? J Neuropathol Exp Neurol. 2018;77:661–664. - PubMed
    1. Muller M., Cooper L.T., Heidecker B. Diagnosis, risk stratification and management of myocarditis. Heart. 2022;108:1486–1497. - PubMed
    1. Cho J., Kim H.S., Ku B.M., et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019;37:2162–2170. - PubMed
    1. Giaccone G., Kim C., Thompson J., et al. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol. 2018;19:347–355. - PMC - PubMed

LinkOut - more resources